A Rare Case of Chorea-Acanthocytosis in India: Clinical Presentation, Diagnosis, and Management
Main Article Content
Abstract
Chorea-acanthocytosis (ChAc) is a rare autosomal recessive neurodegenerative disorder classified under Neuroacanthocytosis syndromes. It is characterized by progressive neurological decline, psychiatric symptoms, and the presence of irregularly shaped red blood cells (acanthocytes) on peripheral blood smears. ChAc remains underdiagnosed due to its rarity and variable presentation. This case report describes a 44-year-old male from India, born of a consanguineous marriage, who presented with self-mutilating lip-biting or lingual dystonia, generalized chorea, and a history of seizures. The patient exhibited psychiatric symptoms including depression and agitation in addition to neurological features such as hypophonic speech, slowed saccades, and hypotonia. Initial diagnoses of tardive dyskinesia and generalized tonic-clonic seizures were revised following referral to neurology. Peripheral blood smears revealed acanthocytosis, and whole-exome sequencing confirmed a homozygous mutation in the VPS13A gene, leading to the diagnosis of ChAc. MRI findings included bilateral caudate and lentiform nucleus atrophy, with mild cerebral atrophy. The patient was treated symptoms were managed with antiepileptics, dopamine receptor antagonists, anticholinergics and vitamin supplementation, and vitamin supplementation, resulting in significant improvement in mandibular and lingual symptoms. Dental guards were provided to prevent further oral injury. This case highlights the importance of considering ChAc in patients presenting with neuropsychiatric and movement disorder symptoms, especially in the context of consanguinity. Early recognition and multidisciplinary management are crucial to improving quality of life. By documenting this rare case, we aim to enhance clinical awareness and facilitate early diagnosis of ChAc in resource-limited settings.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Strijkova-Kenderova V, Todinova S, Andreeva T, Bogdanova D, Langari A, Danailova A, et al. Morphometry and stiffness of red blood cells-signatures of neurodegenerative diseases and aging. Int J Mol Sci. 2021;23:227. PubMed PMID: 35008653
Rashid S, Malek N, Krommyda M. Chorea-acanthocytosis. Pract Neurol. 2024;24:223-5.
Shrestha G, Nepal G, Prust M. Developing systems of emergency and inpatient neurologic care in resource-limited settings. Semin Neurol. 2024;44:105–18.
Sugumaran R, Bhuvaneswaran R. A man with progressive chorea and abnormal trunk movements. Cureus. 2024;16(6):e62004. PubMed PMID: 38989367
Akaishi T, Fujimori J, Nakashima I. Basal ganglia atrophy and impaired cognitive processing speed in multiple sclerosis. Cureus. 2024;16:e52603. PubMed PMID: 38374834
Hames A, Khan S, Gilliland C, Goldman L, Lo HW, Magda K, et al. Carriers of autosomal recessive conditions: are they really ‘unaffected?’. J Med Genet. 2023;61:1–7.
Zhong W, Meng X, Zhu L, Yang X, Wang W, Sun Z, et al. The efficacy of robot-assisted surgery on minor basal ganglia cerebral hemorrhage with neurological dysfunction. Neurosurg Rev. 2024;47:359. PubMed PMID: 39060801.
Yu H, Li L, Li X, Liu H. Clinical features and novel pathogenic variants of Chinese patients with McLeod syndrome and chorea-acanthocytosis. Mol Genet Genomic Med. 2024;12:e70015. PubMed PMID: 39324427
Feinstein A, Stergiopoulos V, Fine J, Lang AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:169–76.
Liu Y, Liu Z-Y, Wan X-H, Guo Y. Progress in the diagnosis and management of chorea-acanthocytosis. Chin Med Sci J. 2018;33:53–9.
Hermann A, Walker RH. Diagnosis and treatment of chorea syndromes. Curr Neurol Neurosci Rep. 2015;15:514. PubMed PMID: 25620691
Chen J, Zhou Z, Luo S, Liu G, Xiang J, Tian Z. Progress of advanced nanomaterials in diagnosis of neurodegenerative diseases. Biosens Bioelectron. 2022;217:114717. PubMed PMID: 36179434.
Dobson-Stone C, Velayos-Baeza A, Filippone LA, Westbury S, Storch A, Erdmann T, et al. Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol. 2004;56:299-302.
Flotte TR, Gessler DJ. Gene therapy for rare neurological disorders. Clin Pharmacol Ther. 2022;111:743–57.
Peikert K, Danek A, Hermann A. Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome. Eur J Med Genet. 2018;61: 699–705.
Huang S, Zhang J, Tao M, Lv Y, Xu L, Liang Z. Two case reports of chorea-acanthocytosis and review of literature. Eur J Med Res. 2022;27:22. PubMed PMID: 35130982
Postert T, Lack B, Kuhn W, Jergas M, Andrich J, Braun B, et al. Basal ganglia alterations and brain atrophy in Huntington’s disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry. 1999;67:457–62.
Feinstein A, Stergiopoulos V, Fine J, Lang AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Cognitive and Behavioral Neurology. 2001 Jul 1;14:169-76.
George R, Kovak K, Cox SL. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Couns. 2015;24:388–99.